Despite their critical and distinct roles, most studies examining CD4+ T cells in CRC have relied on bulk tissue analyses, such as whole blood, which fail to capture the dynamic activation and gene expression changes of these cells. The gene discussed is CD4; the disease is colorectal carcinoma.